Zobrazeno 1 - 10
of 630
pro vyhledávání: '"Ko HJ"'
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 18, Pp 845-858 (2024)
Ji-Eun Song,1 Hae-Jin Ko,2 A-Sol Kim1 1Department of Family Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Korea; 2Department of Family Medicine, School of Medicine, Kyungpook Natio
Externí odkaz:
https://doaj.org/article/38d052a65bfa4ab59950ea7231558f32
Publikováno v:
Clinical Interventions in Aging, Vol Volume 17, Pp 1919-1929 (2022)
Ji-Yeon Park,1 Hae-Jin Ko,1,2 Ji-Eun Song,3 Sang-Min Ji,4 So-Yun Kim4 1Department of Family Medicine, Kyungpook National University Hospital, Daegu, Korea; 2Department of Family Medicine, School of Medicine, Kyungpook National University, Daegu, Kore
Externí odkaz:
https://doaj.org/article/40837d38d8d84860b9c0ae1c314c7154
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 15, Pp 2031-2042 (2022)
Eunji Yun,1 Hey Jin Ko,2 Boryung Ahn,3 Hyejin Lee,4,5 Won Mo Jang,6,7,* Jin Yong Lee7,8,* 1Division of Pharmaceutical Policy Research, HIRA Research Institute, Health Insurance Review & Assessment Service, Wonju-si, Gangwon-do, Republic of Ko
Externí odkaz:
https://doaj.org/article/cafee89b3f9744a78d73aea8596e8140
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 14, Pp 1637-1647 (2021)
Hye-In Choi,1 Hae-Jin Ko,2 Ji-Eun Song,3 Ji-Yeon Park,3 Jin-Hee Kim3 1Department of Family Medicine, Kyungpook National University Hospital, Daegu, Korea; 2Department of Family Medicine, Kyungpook National University Hospital, Kyungpook National Univ
Externí odkaz:
https://doaj.org/article/7d4d8f4fbc80426288071de24247498c
Publikováno v:
Cancer Management and Research, Vol Volume 12, Pp 8275-8285 (2020)
Yenlin Huang,1,2 Chieh Lin,3 Huang-Kai Kao,2,4 Shao-Yu Hung,4 Hung-Ju Ko,2 Yu-Chen Huang,5 Yu-Liang Chang,5 Kai-Ping Chang2,6 1Department of Anatomic Pathology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 2College of Medicine, Chang Gung Universit
Externí odkaz:
https://doaj.org/article/3d77f4d485344d9684e85fe05ff5c3b6
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 11, Pp 149-157 (2018)
A-Sol Kim,1,2 Hae-Jin Ko1,3 1Department of Family Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea; 2Department of Family Medicine, Kyungpook National University Chilgok Hospital, Daegu, South Korea; 3Department of Fami
Externí odkaz:
https://doaj.org/article/1e32a098f5124c2584e10b7810f7e847
Autor:
Ko Hj, Kwon Be, Kim Hm, Kwon Mh, Chang Sy, Park Ek, Lee Es, Huh Jh, Choon Hee Chung, Lee Br, Mi-Na Kweon, Kim Ph
Publikováno v:
International Journal of Obesity (2005)
Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis are characterized by an increase in hepatic triglyceride content with infiltration of immune cells, which can cause steatohepatitis and hepatic insulin resistance. C-C chemokine rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d32b91cbd28f9b30eeeb683c45374601
https://doi.org/10.1038/ijo.2017.200
https://doi.org/10.1038/ijo.2017.200
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S158-S158
The P2Y(6) receptor is a cytoprotective G-protein-coupled receptor (GPCR) activated by UDP (EC50 = 0.30 mu M). We compared and combined modifications to enhance P2Y(6) receptor agonist selectivity, including ribose ring constraint, 5-iodo and 4-alkyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10007::f51c4b46c2a289eab2464ed74ef49c3f
https://hdl.handle.net/20.500.11831/6849
https://hdl.handle.net/20.500.11831/6849
Publikováno v:
Biomedical Research. 15:231-240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8012f784e52e3560c572d961c3459924
https://doi.org/10.2220/biomedres.15.231
https://doi.org/10.2220/biomedres.15.231